Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.5 GBX | -1.33% | -9.76% | -15.91% |
Feb. 28 | Redx Pharma Doses First Patient in Early-stage Trial of Inflammatory Bowel Disease Treatment | MT |
Feb. 28 | Redx Announces That First Participant Dosed in Phase 1 Trial of RXC008 | CI |
- Stock
- Equities
- Stock Redx Pharma Plc - London S.E.
- News Redx Pharma Plc